• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服胰岛素不会改变 NOD 小鼠的肠道微生物组成。

Oral insulin does not alter gut microbiota composition of NOD mice.

机构信息

Department of Veterinary and Animal Sciences, University of Copenhagen, Copenhagen, Denmark.

Department of Food Science, University of Copenhagen, Copenhagen, Denmark.

出版信息

Diabetes Metab Res Rev. 2018 Sep;34(6):e3010. doi: 10.1002/dmrr.3010. Epub 2018 May 1.

DOI:10.1002/dmrr.3010
PMID:29637693
Abstract

BACKGROUND

Oral insulin as a preventive strategy and/or treatment of type 1 diabetes has been the target of much research. Producing oral insulins is a complex and challenging task, with numerous pitfalls, due to physiological, physical, and biochemical barriers. Our aim was to determine the impact of oral insulin on the delicate gut microbiota composition.

METHODS

Female nonobese diabetic mice were given oral porcine insulin 2 times a week from 5 weeks of age for 4 weeks, and then subsequently once a week for 21 weeks, or until euthanized. The mice were divided into groups on a gluten-reduced diet or a standard diet. Gut microbiota composition was analysed based on faecal samples, and the type 1 diabetes incidence of the mice was monitored.

RESULTS

We observed no influence of the oral porcine insulin on the gut microbiota composition of mice on a gluten-reduced or a standard diet at 9 weeks of age. Also, the administration of oral insulin did not influence the incidence of type 1 diabetes at 30 weeks of age.

CONCLUSIONS

Oral porcine insulin does not alter the gut microbiota composition of nonobese diabetic mice on either a gluten-reduced diet or standard diet. Also, the oral porcine insulin did not influence the incidence of type 1 diabetes in the groups.

摘要

背景

口服胰岛素作为预防策略和/或治疗 1 型糖尿病一直是许多研究的目标。由于生理、物理和生化屏障,生产口服胰岛素是一项复杂且具有挑战性的任务,存在许多陷阱。我们的目的是确定口服胰岛素对肠道微生物群组成的影响。

方法

从 5 周龄开始,每周给雌性非肥胖型糖尿病(NOD)小鼠口服猪胰岛素 2 次,持续 4 周,然后每周 1 次,持续 21 周,或直至处死。将小鼠分为谷朊粉减少饮食组或标准饮食组。根据粪便样本分析肠道微生物群组成,并监测小鼠 1 型糖尿病的发病率。

结果

我们观察到,在 9 周龄时,口服猪胰岛素对谷朊粉减少饮食或标准饮食的小鼠肠道微生物群组成没有影响。此外,口服胰岛素的给予也没有影响 30 周龄时 1 型糖尿病的发病率。

结论

口服猪胰岛素不会改变谷朊粉减少饮食或标准饮食的 NOD 小鼠的肠道微生物群组成。此外,口服猪胰岛素也不会影响各组 1 型糖尿病的发病率。

相似文献

1
Oral insulin does not alter gut microbiota composition of NOD mice.口服胰岛素不会改变 NOD 小鼠的肠道微生物组成。
Diabetes Metab Res Rev. 2018 Sep;34(6):e3010. doi: 10.1002/dmrr.3010. Epub 2018 May 1.
2
Modulation of Gut Microbiota by Low Methoxyl Pectin Attenuates Type 1 Diabetes in Non-obese Diabetic Mice.低甲氧基果胶通过调节肠道微生物群减轻非肥胖型糖尿病小鼠的 1 型糖尿病。
Front Immunol. 2019 Jul 30;10:1733. doi: 10.3389/fimmu.2019.01733. eCollection 2019.
3
Clostridial Butyrate Biosynthesis Enzymes Are Significantly Depleted in the Gut Microbiota of Nonobese Diabetic Mice.丁酸梭菌生物合成酶在非肥胖型糖尿病小鼠肠道微生物群中明显耗竭。
mSphere. 2018 Oct 24;3(5):e00492-18. doi: 10.1128/mSphere.00492-18.
4
Evaluation of different mucosal microbiota leads to gut microbiota-based prediction of type 1 diabetes in NOD mice.不同黏膜微生物群的评估导致基于肠道微生物群的 NOD 小鼠 1 型糖尿病预测。
Sci Rep. 2018 Oct 18;8(1):15451. doi: 10.1038/s41598-018-33571-z.
5
Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes.早期使用抗生素会改变肠道微生物群,并增加自身免疫性胰岛素依赖型糖尿病自发小鼠模型中的疾病发生率。
PLoS One. 2015 May 13;10(5):e0125448. doi: 10.1371/journal.pone.0125448. eCollection 2015.
6
Depletion of the diabetic gut microbiota resistance enhances stem cells therapy in type 1 diabetes mellitus.耗竭糖尿病肠道微生物群抗性可增强 1 型糖尿病中的干细胞疗法。
Theranostics. 2020 May 17;10(14):6500-6516. doi: 10.7150/thno.44113. eCollection 2020.
7
Interleukin-37 sensitize the elderly type 2 diabetic patients to insulin therapy through suppressing the gut microbiota dysbiosis.白细胞介素-37 通过抑制肠道微生物群失调使老年 2 型糖尿病患者对胰岛素治疗敏感。
Mol Immunol. 2019 Aug;112:322-329. doi: 10.1016/j.molimm.2019.06.008. Epub 2019 Jun 22.
8
Early-life exposure to gut microbiota from disease-protected mice does not impact disease outcome in type 1 diabetes susceptible NOD mice.生命早期暴露于来自疾病保护型小鼠的肠道微生物群不会影响易患 1 型糖尿病的 NOD 小鼠的疾病结局。
Immunol Cell Biol. 2019 Jan;97(1):97-103. doi: 10.1111/imcb.12201. Epub 2018 Oct 9.
9
Prolonged antibiotic treatment induces a diabetogenic intestinal microbiome that accelerates diabetes in NOD mice.长期抗生素治疗会诱导产生一种致糖尿病的肠道微生物群,加速非肥胖糖尿病(NOD)小鼠的糖尿病进程。
ISME J. 2016 Feb;10(2):321-32. doi: 10.1038/ismej.2015.114. Epub 2015 Aug 14.
10
Gut Microbiota and Type 1 Diabetes.肠道微生物群与 1 型糖尿病。
Int J Mol Sci. 2018 Mar 27;19(4):995. doi: 10.3390/ijms19040995.

引用本文的文献

1
Changes in the Global Epidemiology of Type 1 Diabetes in an Evolving Landscape of Environmental Factors: Causes, Challenges, and Opportunities.全球环境因素不断变化背景下 1 型糖尿病的全球流行病学变化:病因、挑战与机遇。
Medicina (Kaunas). 2023 Mar 28;59(4):668. doi: 10.3390/medicina59040668.
2
Roles of Gut Microbiome in Bone Homeostasis and Its Relationship with Bone-Related Diseases.肠道微生物群在骨稳态中的作用及其与骨相关疾病的关系。
Biology (Basel). 2022 Sep 26;11(10):1402. doi: 10.3390/biology11101402.
3
Effect of gluten-free diet and antibiotics on murine gut microbiota and immune response to tetanus vaccination.
无麸质饮食和抗生素对小鼠肠道微生物群和破伤风疫苗免疫反应的影响。
PLoS One. 2022 Apr 13;17(4):e0266719. doi: 10.1371/journal.pone.0266719. eCollection 2022.
4
The Relationships between Gut Microbiota and Diabetes Mellitus, and Treatments for Diabetes Mellitus.肠道微生物群与糖尿病之间的关系以及糖尿病的治疗方法。
Biomedicines. 2022 Jan 28;10(2):308. doi: 10.3390/biomedicines10020308.
5
Gut microbiome in type 1 diabetes: A comprehensive review.1 型糖尿病中的肠道微生物组:全面综述。
Diabetes Metab Res Rev. 2018 Oct;34(7):e3043. doi: 10.1002/dmrr.3043. Epub 2018 Jul 17.